• SENSEX 81,087.69
    -97.89 (--0.12%)
  • BANKNIFTY 55,617.60
    -344.35 (--0.62%)
  • Tata Motors
    647.20 542.55(%)
  • Axis Bank
    1,060.20 934.00(%)
  • Vimta Labs
    677.30 235.00(%)
  • GE Vernova T&D
    2,871.15 2,871.15(%)
  • Netweb Technol.
    2,299.15 3,060.00(%)
  • Suzlon Energy
    66.80 86.04(%)
  • Kaynes Tech
    6,483.00 7,824.95(%)
  • M & M
    3,117.25 2,360.45(%)
  • PNB Housing
    803.30 746.10(%)
  • Waaree Energies
    3,163.55 3,740.75(%)
  • HDFC Bank
    2,010.00 1,593.20(%)
  • Jayaswal Neco
    48.32 26.06(%)
  • Skipper
    548.00 665.00(%)
  • Shree Refrigerat
    177.70 177.70(%)
  • Timex Group
    244.75 289.90(%)
  • Hind. Unilever
    2,728.10 3,034.50(%)
  • TCS
    3,000.00 3,000.00(%)
  • Ceinsys Tech
    1,750.85 538.20(%)
  • Swiggy
    386.25 297.00(%)
  • KIOCL
    374.20 461.35(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Natco Pharma Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln

  • Natco
  • BSE Code : 4684.0
  • ISIN : INE987B01026
931.05 -22 (-2.34%)
  • As on 02 Aug 2025 (EOD)

  • Today’s Low

    921.00

  • Today’s High

    953.00

  • Open

    952.75

  • Perv Close

    953.40

  • 52W Low

    726.80

  • 52W High

    1,639.00

Key Indicators

  • P/E(TTM)

    8.97

  • Mar.Cap (₹Cr.)

    16,676.02

  • Div & Yield %

    0.65

  • Book Value(₹)

    409.46

  • Debt-Equity Ratio

    -2.34

  • AGM Date

    01-Aug-2025

  • EPS

    103.31

  • P/E Ratio

    8.97

Financials Ratios

  • Debt-Equity Ratio

    0.05

  • Mar.Cap (₹Cr.)

    16,676.02

  • RONW (%)

    25.88

  • ROCE (%)

    29.63

Score Board

  • Equity (₹ in Cr.)

    35.82

  • BV (₹)

    409.50

  • Sales( ₹ in Cr.)

    4,094.50

  • NP (in Cr.)

    1,850.40

  • NP Var(%)

    41.0

  • Div%

    300.0

  • CPS (₹)

    115.60

  • EPS (₹)

    103.30

  • Traded Value (₹ in Lakhs)

    16,591.84

  • 52 Week High

    1,639.00

  • 52 Week Low

    726.80

  • Price BSE

    926.0

  • Price NSE

    931.00

  • Market Capital( in Cr.)

    16,591.84

  • P/C Ratio

    8.00

  • P/E Ratio

    9.00

  • Price Vs.BV

    103.30

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar
INCOME :            
Sales Turnover 3,568.90 2,351.00 1,767.80 1,653.50 1,790.20 1,986.30
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 3,568.90 2,351.00 1,767.80 1,653.50 1,790.20 1,986.30
Other Income 104.70 85.50 94.60 101.10 123.80 129.80
Stock Adjustments -17.20 -34.60 5.50 46.90 55.90 25.50
Total Income 3,656.40 2,401.90 1,867.90 1,801.50 1,969.90 2,141.60
EXPENDITURE :            
Raw Materials 557.30 495.10 540.10 546.90 452.90 364.60
Power and Fuel Cost 88.90 81.90 76.40 59.40 62.40 59.60
Employee Cost 454.90 425.70 410.10 380.00 356.10 340.20
Other Manufacturing Expenses 179.80 150.30 148.70 114.30 134.70 119.70
Selling and Administration Expenses 483.70 290.70 309.10 140.30 202.30 253.70
Miscellaneous Expenses 150.10 28.00 75.90 41.90 59.70 57.50
Employee Benefit Expenses 454.90 425.70 410.10 380.00 356.10 340.20
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 1,914.70 1,471.70 1,560.30 1,282.80 1,268.10 1,195.30
Operating Profit 1,741.70 930.20 307.60 518.70 701.80 946.30
Interest 14.50 8.60 13.30 11.30 20.60 18.80
Gross Profit 1,727.20 921.60 294.30 507.40 681.20 927.50
Depreciation 171.90 150.90 138.40 115.20 98.10 80.10
Profit Before Tax 1,555.30 770.70 155.90 392.20 583.10 847.40
Current Tax 284.80 133.10 32.50 93.30 129.10 186.30
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax -36.10 0.50 -15.70 -10.60 -20.50 -6.00
Reported Net Profit 1,306.60 637.10 139.10 309.50 474.50 667.10
Extraordinary Items -2.12 14.71 33.80 24.39 12.69 10.53
Adjusted Net Profit 1,308.72 622.39 105.30 285.11 461.81 656.57
Adjustment below Net Profit -49.70 -1.00 0.40 2.20 -31.40 -27.40
P & L Balance brought forward 3,134.60 2,587.10 2,520.50 2,322.50 2,006.80 1,459.00
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 165.20 88.60 72.90 113.90 127.40 91.90
P & L Balance carried down 4,226.30 3,134.60 2,587.10 2,520.30 2,322.50 2,006.80
Dividend 170.20 100.40 82.10 113.90 127.40 91.90
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 475.00 275.00 225.00 262.50 337.50 312.50
Dividend Per Share(Rs) 9.50 5.50 4.50 5.25 6.75 6.25
Earnings Per Share-Unit Curr 72.99 34.91 7.62 16.96 26.07 36.55
Earnings Per Share(Adj)-Unit Curr 72.99 34.91 7.62 16.96 26.07 36.55
Book Value 312.42 257.64 229.69 224.17 212.61 195.24
Book Value(Adj)-Unit Curr 312.42 257.64 229.69 224.17 212.61 195.24

Shareholding Pattern

  • Promoter Group

    49.56%

  • Public Share Holding

    50.44%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 746,910 746,910.00 746,910 746,910
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 746,910 0.42 746,910 2
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 33,070,070 18.46 33,070,070 4
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 50,267,145 28.07 50,267,145 12
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 4,686,150 2.62 4,686,150 4
Others 0 0.00 0 0
Sub Total 88,023,365 49.14 88,023,365 20
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 864 0.00 864 1
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 65 0.00 65 2
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 27,786,067 15.51 27,786,067 239
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 6,137,761 3.43 6,137,761 12
Mutual Funds / UTI 3,787,591 2.11 3,787,591 47
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 493,838 0.28 493,838 16
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 38,206,186 21.33 38,206,186 317
2] Non Institution
Bodies Corporate 3,365,052 1.88 3,361,252 1,138
Clearing Members 3,323 0.00 3,323 8
Directors of their Relatives 120,023 0.07 120,023 10
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 2,571,775 1.44 2,570,775 9,666
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 0 0.00 0 0
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 5,984,785 3.34 5,984,785 18
Individuals holding nominal share capital up to Rs. 1 lakh 39,182,261 21.88 38,810,431 418,245
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 2,001 0.00 2,001 7
Others 904,189 0.50 904,189 3
Sub Total 52,133,409 29.11 51,756,779 429,095
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 179,109,870 100.00 178,733,240 429,434

Company Background

Natco Pharma LtdPharmaceuticals - Indian - Bulk Drugs & Formln

  • Natco Pharma Ltd
  • BSE Code : 4684.0
  • ISIN : INE987B01026

  • Incorporation Year

    1981

  • Registered Office

    Natco House
    Road No 2 Banjara Hills, Hyderabad,
    Telangana-500033

  • Telephone

    91-040-23547532

  • FAX

    91-040-23548243

  • Chairman

    V C Nannapaneni

  • Managing Director

    V C Nannapaneni

  • Company Secretary

    Venkat Ramesh

  • Auditor

    B S R & Co

  • Face Value

    2

  • Listing

    NSE

  • Registrar

    Venture Capital & Corp. Inv.
    12-10-167 ,
    ,Bharath Nagar
    Mumbai - Hyderbad - 500018

Natco Pharma Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Natco Pharma 926.35 3,673.60 3,568.90 8.97 28.58
Abbott India 33,676.00 6,684.73 6,409.15 50.59 44.95
Astrazeneca Phar 8,893.15 1,756.92 1,716.29 192.08 32.94
P & G Health Ltd 6,199.70 1,166.89 1,151.26 40.97 39.76
Glaxosmi. Pharma 2,933.90 3,866.05 3,723.49 52.76 58.72
Cipla 1,501.20 20,029.57 19,044.85 22.44 21.40
Amrutanjan Healt 676.35 437.58 421.23 38.47 20.84
Guj. Themis Bio. 371.85 174.19 169.82 90.92 44.82
Fermenta Biotec. 362.00 442.21 430.53 15.76 17.61
Bliss GVS Pharma 173.70 703.42 667.20 25.96 9.16
Ambalal Sarabhai 32.97 19.33 4.04 30.53 2.10